Novartis reported $7.13B in Stock for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Amgen AMGN:US $ 4152M 37M
Aphria Inc APH:CN C$ 340.86M 9.58M
Biogen BIIB:US $ 1347.9M 93.1M
Bristol Myers Squibb BMY:US $ 2163M 26M
Canopy Growth Corp WEED:CN C$ 86.9M 324.77M
Catalent CTLT:US $ 622M 29M
Corcept Therapeutics CORT:US $ 4.99M 0.32M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Endo International Ordinary Shares ENDP:US $ 297.3M 41.15M
Gilead Sciences GILD:US $ 2797M 191M
GlaxoSmithKline GSK:LN 6244M 86M
Horizon Pharma HZNP:US $ 237.43M 21.24M
JAZZ PHA JAZZ:US $ 1137.85M 113.41M
Lannett LCI:US $ 112.64M 3.09M
Novartis NOVN:VX SF 6885M 226M
Pacira Pharmaceuticals PCRX:US $ 67.21M 1.94M
Perrigo Ordinary Shares PRGO:US $ 1092.5M 23.4M
Phibro Animal Health PAHC:US $ 221.31M 5M
Prestige Brands PBH:US $ 107.92M 2.37M
Supernus Pharmaceuticals SUPN:US $ 60.16M 1.76M
Teva Pharmaceutical Industries TEVA:US $ 4167M 195M
Valeant Pharmaceuticals VRX:CN $ 1058M 28M
Zoetis ZTS:US $ 1875M 73M